Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant
HAEMATOLOGICA（2024）
摘要
Not available.
更多查看译文
关键词
lymphoblastic leukemia,lymphoblastic leukemia refractory,vedotin combination therapy,conventional chemotherapy,t-cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要